Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Peroralna primjena"'
Publikováno v:
Liječnički vjesnik
Volume 139
Issue 3-4
Volume 139
Issue 3-4
Cilj terapije antagonistima vitamina K (varfarin) i novim oralnim antikoagulantnim lijekovima (NOAK-ima) jesu prevencija moždanog udara i drugih embolija kod bolesnika s nevalvularnom fibrilacijom atrija te liječenje i prevencija venske tromboembol
Autor:
Dinka, Pavičić Baldani, Lana, Skrgatić, Velimir, Simunić, Vesna, Elvedi Gasparović, Blaž, Geršak
Publikováno v:
Liječnički vjesnik
Volume 137
Issue 1-2
Volume 137
Issue 1-2
Venska tromboembolija (VTE) najvažniji je neželjeni učinak hormonskoga nadomjesnog liječenja (HNL). Biološke i epidemiološke studije pokazale su da oralna primjena estrogena nosi povišen rizik od nastanka VTE-a u odnosu na transdermalnu primje
Publikováno v:
Acta Pharmaceutica
Volume 57
Issue 1
Volume 57
Issue 1
The objective of the present work was to formulate a self-emulsifying drug delivery system (SEDDS) for simvastatin, which is widely used in the treatment of hypercholesterolemia and dyslipidemia as an adjunct to diet. Simvastatin SEDDS were formulate
Publikováno v:
Acta Pharmaceutica
Volume 57
Issue 2
Volume 57
Issue 2
An investigation into the suitability of mucuna gum microspheres for oral delivery of glibenclamide is presented. Mucuna gum microspheres were formulated under different conditions of polymer concentration and crosslinking time at constant speed. The
Publikováno v:
Acta Pharmaceutica
Volume 55
Issue 2
Volume 55
Issue 2
The objective of this review article is to explain the use of cyclodextrin in the different routes of drug administration. The article gives the chemistry of cyclodextrins and addresses the issue of the mechanism of drug release from cyclodextrin com
Autor:
Jug, Mario, Bećirević-Laćan, Mira
Publikováno v:
Farmaceutski glasnik
Volume 80
Issue 5
Volume 80
Issue 5
Peroral drug application is the most preferred by patients and clinicians, but is also connected with many problems such as pH or enzymatic drug degradation in gastrointestinal tract or metabolic inactivation after first pass in liver. By applying th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3671::70795a52376c86d142ea337598231dc3
https://repozitorij.pharma.unizg.hr/islandora/object/pharma:1721/datastream/FILE0
https://repozitorij.pharma.unizg.hr/islandora/object/pharma:1721/datastream/FILE0